Redeye Growth Day – 2 June 2021

Magnus Corfitzen will present at the Redeye Growth day. Registration link to the broadcast : https://www.lyyti.in/Redeye_GrowthDay_2021 Live broadcast and schedule: https://www.redeye.se/events/808637/redeye-growth-day-2021

Redeye Growth Day – 2 June 2021

Magnus Corfitzen will present at the Redeye Growth day. Registration link to the broadcast : https://www.lyyti.in/Redeye_GrowthDay_2021 Live broadcast and schedule: https://www.redeye.se/events/808637/redeye-growth-day-2021

MVA Oncology Network Meeting – Development Of Orphan Drugs Within Oncology

Andreas Norlin, Project Director and Head of Non-clinical Development will participate at the MVA ONCOLOGY NETWORK MEETING. Andreas will share his knowledge: - Building an Orphan Oncology company: past experience and future perspectives To sign up: https://mva.org/event/mva-oncology-network-meeting-orphan-oncology/

MVA Oncology Network Meeting – Development Of Orphan Drugs Within Oncology

Andreas Norlin, Project Director and Head of Non-clinical Development will participate at the MVA ONCOLOGY NETWORK MEETING. Andreas will share his knowledge: - Building an Orphan Oncology company: past experience and future perspectives To sign up: https://mva.org/event/mva-oncology-network-meeting-orphan-oncology/

LSX Nordic Congress – 4th Annual Congress (Virtual)

Magnus Corfitzen, CEO at Ascelia Pharma  will attend the LSX Nordic Congress, he will also participate in the panel discussion: Preparing for and Executing Successful Cross-Border Transations   

LSX Nordic Congress – 4th Annual Congress (Virtual)

Magnus Corfitzen, CEO at Ascelia Pharma  will attend the LSX Nordic Congress, he will also participate in the panel discussion: Preparing for and Executing Successful Cross-Border Transations